NovelStem International Corp.

General ticker "NSTM" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.2M (TTM average)

NovelStem International Corp. does not follow the US Stock Market performance with the rate: -17.7%.

Estimated limits based on current volatility of 16.1%: low 0.02$, high 0.03$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.03$, 0.12$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.03$, 0.11$]

Financial Metrics affecting the NSTM estimates:

  • Negative: Non-GAAP EPS, $ of -0.09 <= 0.04
  • Negative: negative Net income
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -9.05 <= 1.76
  • Negative: Shareholder equity ratio, % of -86.56 <= 22.51
  • Negative: 0 < Interest expense per share, $ of 0
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term NSTM quotes

Long-term NSTM plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.01MM $0.01MM $0.01MM
Operating Expenses $0.43MM $3.54MM $0.94MM
Operating Income $-0.42MM $-3.53MM $-0.93MM
Non-Operating Income $-0.01MM $-0.36MM $-2.14MM
Interest Expense $0.01MM $0.10MM $0.43MM
Income(Loss) $-0.43MM $-3.88MM $-3.07MM
Taxes $0.33MM $0.30MM $0.16MM
Profit(Loss)* $-0.77MM $-4.19MM $-3.23MM
Stockholders Equity $1.93MM $-1.95MM $-5.14MM
Assets $2.29MM $2.25MM $0.16MM
Operating Cash Flow $-0.18MM $-0.35MM $-0.27MM
Investing Cash Flow $0.00MM $-0.25MM $-0.25MM
Financing Cash Flow $0.18MM $0.65MM $0.47MM
Earnings Per Share** $-0.02 $-0.09 $-0.07

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.